Mitochondrial Medicine in Health and Disease: Interface Between Athletic Performance and Therapeutics

Genetic and Molecular Aspects of Sport Performance

Volumn , Issue , 2010, Pages 14-32

  Wallace, Douglas C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Electron transport chain (ETC); Genetics of the nDNA Mitochondrial Genes and Disease Mutations; Leber's hereditary optic neuropathy (LHON); Mitochondrial Function; Mitochondrial Medicine in Health and Disease: Interface Between Athletic Performance and Therapeutics Bioenergetic Genetics; Mitochondrial Therapeutics and Performance Enhancement; Myoclonic epilepsy and ragged red fiber disease (MERRF); The Nature of the Mitochondrial Genome; The Role of mtDNA Mutations in Health and Disease; Therapeutic Approaches to Enhance Mitochondrial Function

Indexed keywords

EID: 84885547073     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444327335.ch2     Document Type: Chapter

References (149)

1. Angelin, A., Tiepolo, T., Sabatelli, P., et al. (2007). Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proceedings of the National Academy of Sciences USA 104(3), 991-996.
2. Argov, Z., Bank, W.J., Maris, J., et al. (1986). Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Annals of Neurology 19(6), 598-602.
3. Bai, R.K., Leal, S.M., Covarrubias, D., Liu, A. & Wong, L.J. (2007). Mitochondrial genetic background modifies breast cancer risk. Cancer Research 67(10), 4687-4694.
4. Bai, Y., Hajek, P., Chomyn, A., et al. (2001). Lack of complex I activity in human cells carrying a mutation in mtDNAencoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADHquinone oxidoreductase (NDI1) gene. Journal of Biological Chemistry 276(42), 38808-38813.
5. Ballinger, S.W., Shoffner, J.M., Hedaya, E.V., et al. (1992). Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genetics 1(1), 11-15.
6. Ballinger, S.W., Shoffner, J.M., Gebhart, S., Koontz, D.A. & Wallace, D.C. (1994). Mitochondrial diabetes revisited. Nature Genetics 7(4), 458-459.
7. Bastin, J., Aubey, F., Rotig, A., Munnich, A.& Djouadi, F. (2008). Activation of peroxisome proliferatoractivated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. Journal of Clinical Endocrinology and Metabolism 93(4), 1433-1441.
8. Baudouin, S.V., Saunders, D., Tiangyou, W., et al. (2005). Mitochondrial DNA and survival after sepsis: A prospective study. Lancet 366(9503), 2118-2121.
9. Bender, A., Krishnan, K.J., Morris, C.M., et al. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genetics 38(5), 515-517.
10. Booker, L.M., Habermacher, G.M., Jessie, B.C., et al. (2006). North American white mitochondrial haplogroups in prostate and renal cancer. Journal of Urology 175(2), 468-472.
11. Bowmaker, M., Yang, M.Y., Yasukawa, T., et al. (2003). Mammalian mitochondrial DNA replicates bidirectionally from an initiation zone. Journal of Biological Chemistry 278(51), 50961-50969.
12. Brandon, M., Baldi, P. & Wallace, D.C. (2006) Mitochondrial mutations in cancer. Oncogene 25(34), 4647-4662.
13. Brown, M.D., Torroni, A., Reckord, C.L. & Wallace, D.C. (1995). Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNAs indicates multiple independent occurrences of the common mutations. Human Mutation 6(4), 311-325.
14. Brown, M.D., Sun, F. &Wallace, D.C. (1997). Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. American Journal of Human Genetics 60(2), 381-387.
15. Brown, M.D., Starikovskaya, E., Derbeneva, O., et al. (2002). The role of mtDNA background in disease expression: A new primary LHON mutation associated with Western Eurasian haplogroup J. Human Genetics 110(2), 130-138.
16. Carrieri, G., Bonafe, M., De Luca, M., et al. (2001). Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Human Genetics 108(3), 194-198.
17. Castro, M.G., Terrados, N., Reguero, J.R., Alvarez, V. & Coto, E. (2007). Mitochondrial haplogroup T is negatively associated with the status of elite endurance athlete. Mitochondrion 7(5), 354-357.
18. Chagnon, P., Gee, M., Filion, M., Robitaille, Y., Belouchi, M. & Gauvreau, D. (1999). Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. American Journal of Medical Genetics 85(1), 20-30.
19. Clayton, D.A. (1982). Replication of animal mitochondrial DNA. Cell 28(4), 693-705.
20. Corral-Debrinski, M., Horton, T., Lott, M.T., Shoffner, J.M., Beal, M.F. & Wallace, D.C. (1992). Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nature Genetics 2(4), 324-329.
21. Corral-Debrinski, M., Horton, T., Lott, M.T., et al. (1994). Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23(2), 471-476.
22. Coskun, P.E., Ruiz-Pesini, E.E. & Wallace, D.C. (2003). Control region mtDNA variants: Longevity, climatic adaptation and a forensic conundrum. Proceedings of the National Academy of Sciences USA 100(5), 2174-2176.
23. Coskun, P.E., Beal, M.F. & Wallace, D.C. (2004). Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proceedings of the National Academy of Sciences USA 101(29), 10726-10731.
24. Crispim, D., Canani, L.H., Gross, J.L., Tschiedel, B., Souto, K.E. & Roisenberg, I. (2006). The European-specific mitochondrial cluster J/T could confer an increased risk of insulin-resistance and type 2 diabetes: An analysis of the m.4216T > C and m.4917A > G variants. Annals of Human Genetics 70(Pt 4), 488-495.
25. Darvishi, K., Sharma, S., Bhat, A.K., Rai, E. & Bamezai, R.N. (2007). Mitochondrial DNA G10398A polymorphism imparts maternal haplogroup-a risk for breast and esophageal cancer. Cancer Letters 249(2), 249-255.
26. De Benedictis, G., Rose, G., Carrieri, G., et al. (1999). Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB Journal 13(12), 1532-1536.
27. Delettre, C., Lenaers, G., Griffoin, J.M., et al. (2000). Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nature Genetics 26(2), 207-210.
28. Di Prospero, N.A., Baker, A., Jeffries, N. & Fischbeck, K.H. (2007). Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial. Lancet Neurology 6(10), 878-886.
29. Djouadi, F. & Bastin, J. (2008). PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. Journal of Inherited Metabolic Disease 31(2), 217-225.
30. Eleff, S., Kennaway, N.G., Buist, N.R., et al. (1984). 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proceedings of the National Academy of Sciences USA 81(11), 3529-3533.
31. Elliott, H.R., Samuels, D.C., Eden, J.A., Relton, C.L. & Chinnery, P.F. (2008). Pathogenic mitochondrial DNA mutations are common in the general population. American Journal of Human Genetics 83(2), 254-260.
32. Fan, W., Waymire, K., Narula, N., et al. (2008). A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319(5865), 958-962.
33. Filipovska, A., Eccles, M.R., Smith, R.A. & Murphy, M.P. (2004). Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation. FEBS Letters 556(1-3), 180-186.
34. Flierl, A., Jackson, C., Cottrell, B., Murdock, D., Seibel, P. & Wallace, D.C. (2003). Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Molecular Therapy 7(4), 550-557.
35. Flierl, A., Chen, Y., Coskun, P.E., Samulski, R.J. & Wallace, D.C. (2005). Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse. Gene Therapy 12(7), 570-578.
36. Fuku, N., Park, K.S., Yamada, Y., et al. (2007). Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. American Journal of Human Genetics 80(3), 407-415.
37. Geromel, V., Cao, A., Briane, D., et al. (2001). Mitochondria transfection by oligonucleotides containing a signal peptide and vectorized by cationic liposomes. Antisense and Nucleic Acid Drug Development 11(3), 175-180.
38. Geromel, V., Darin, N., Chretien, D., et al. (2002). Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: Rationale and comparative benefits. Molecular Genetics and Metabolism 77(1-2), 21-30.
39. Ghezzi, D., Marelli, C., Achilli, A., et al. (2005). Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. European Journal of Human Genetics 13(6), 748-752.
40. Goto, Y., Nonaka, I. & Horai, S. (1990). A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348(6302), 651-653.
41. Guy, J., Qi, X., Pallotti, F., et al. (2002). Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Annals of Neurology 52(5), 534-542.
42. Hakkaart, G.A., Dassa, E.P., Jacobs, H.T. & Rustin, P. (2006). Allotopic expression of a mitochondrial alternative oxidase confers cyanide resistance to human cell respiration. EMBO Reports 7(3), 341-345.
43. Hart, P.E., Lodi, R., Rajagopalan, B., et al. (2005). Antioxidant treatment of patients with Friedreich ataxia: Four-year follow-up. Archives of Neurology 62(4), 621-626.
44. Hendrickson, S.L., Hutcheson, H.B., Ruiz-Pesini, E., et al. (2008). Mitochondrial DNA haplogroups influence AIDS progression. AIDS 22(18), 2429-2439.
45. Hendrickson, S.L., Kingsley, L.A., Ruiz- Pesini, E., et al. (2009). Mitochondrial DNA haplogroups influence lipoatrophy after highly active anti-retroviral therapy. Journal of Acquired Immune Deficiency Syndromes 51(2), 111-116.
46. Holt, I.J. & Jacobs, H.T. (2003). Response: The mitochondrial DNA replication bubble has not burst. Trends in Biochemical Sciences 28(7), 355-356.
47. Holt, I.J., Harding, A.E. & Morgan- Hughes, J.A. (1988). Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331(6158), 717-719.
48. Holt, I.J., Harding, A.E., Petty, R.K. & Morgan-Hughes, J.A. (1990). A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. American Journal of Human Genetics 46(3), 428-433.
49. Irwin, W.A., Bergamin, N., Sabatelli, P., et al. (2003). Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nature Genetics 35(4), 367-371.
50. Ishikawa, K., Takenaga, K., Akimoto, M., et al. (2008). ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320, 661-664.
51. Ivanova, R., Lepage, V., Charron, D. & Schachter, F. (1998). Mitochondrial genotype associated with French Caucasian centenarians. Gerontology 44(6), 349.
52. James, A.M., Smith, R.A. & Murphy, M.P. (2004). Antioxidant and prooxidant properties of mitochondrial coenzyme Q. Archives of Biochemistry and Biophysics 423(1), 47-56.
53. Jauslin, M.L., Meier, T., Smith, R.A. & Murphy, M.P. (2003). Mitochondriatargeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB Journal 17(13), 1972-1974.
54. Jones, M.M., Manwaring, N., Wang, J.J., Rochtchina, E., Mitchell, P. & Sue, C.M. (2007). Mitochondrial DNA haplogroups and age-related maculopathy. Archives of Ophthalmology 125(9), 1235-1240.
55. Kaufmann, P., Engelstad, K., Wei, Y.,et al. (2006). Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology 66(3), 324-330.
56. Kaukonen, J., Juselius, J.K., Tiranti, V., et al. (2000). Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289(5480), 782-785.
57. Kazuno, A.A., Munakata, K., Nagai, T., et al. (2006). Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genetics 2(8), e128.
58. Kelly, D.P. & Scarpulla, R.C. (2004). Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes and Development 18(4), 357-368.
59. Khidr, L., Wu, G., Davila, A., Procaccio, V., Wallace, D. & Lee, W.H. (2008). Role of SUV3 helicase in maintaining mitochondrial homeostasis in human cells. Journal of Biological Chemistry 283(40), 27064-27073.
60. Khusnutdinova, E., Gilyazova, I., Ruiz- Pesini, E., et al. (2008). A mitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease. Annals of the New York Academy of Sciences 1147, 1-20.
61. King, M.P. & Attardi, G. (1989). Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 246(4929), 500-503.
62. Klivenyi, P., Gardian, G., Calingasan, N.Y., et al. (2004). Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity. Neuromolecular Medicine 6(2-3), 87-92.
63. Kraytsberg, Y., Kudryavtseva, E., McKee, A.C., Geula, C., Kowall, N.W. & Khrapko, K. (2006). Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nature Genetics 38(5), 518-520.
64. Lagouge, M., Argmann, C., Gerhart- Hines, Z., et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127(6), 1109-1122.
65. Mandel, H., Szargel, R., Labay, V., et al. (2001). The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nature Genetics 29(3), 337-341.
66. Manfredi, G., Fu, J., Ojaimi, J., et al. (2002). Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nature Genetics 30(4), 394-399.
67. Melov, S., Schneider, J.A., Day, B.J., et al. (1998). A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nature Genetics 18(2), 159-163.
68. Melov, S., Doctrow, S.R., Schneider, J.A., et al. (2001). Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. Journal of Neuroscience 21(21), 8348-8353.
69. Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, G. & Attardi, G. (1999). Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286(5440), 774-779.
70. Milne, J.C., Lambert, P.D., Schenk, S., et al. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450(7170), 712-716.
71. Mishmar, D., Ruiz-Pesini, E.E., Golik, P., et al. (2003). Natural selection shaped regional mtDNA variation in humans. Proceedings of the National Academy of Sciences USA 100(1), 171-176.
72. Mishmar, D., Ruiz-Pesini, E., Mondragon- Palomino, M., Procaccio, V., Gaut, B. & Wallace, D.C. (2006). Adaptive selection of mitochondrial complex I subunits during primate radiation. Gene 378, 11-18.
73. Mohlke, K.L., Jackson, A.U., Scott, L.J., et al. (2005). Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Human Genetics 118(2), 245-254.
74. Niemi, A.K. & Majamaa, K. (2005). Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. European Journal of Human Genetics 13(8), 965-969.
75. Niemi, A.K., Hervonen, A., Hurme, M., Karhunen, P.J., Jylha, M. & Majamaa, K. (2003). Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Human Genetics 112(1), 29-33.
76. Nishigaki, Y., Yamada, Y., Fuku, N., et al. (2007). Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males. Human Genetics 120(6), 827-836.
77. Nishino, I., Spinazzola, A. & Hirano, M. (1999). Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283(5402), 689-692.
78. Ostrander, E.A., Huson, H.J. & Ostrander, G.K. (2009). Genetics of athletic performance. Annual Review of Genomics and Human Genetics 10, 407-429.
79. Palmieri, L., Alberio, S., Pisano, I., et al. (2005). Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Human Molecular Genetics 14(20), 3079-3088.
80. Perales-Clemente, E., Bayona- Bafaluy, M.P., Perez-Martos, A., Barrientos, A., Fernandez-Silva, P. & Enriquez, J.A. (2008). Restoration of electron transport without proton pumping in mammalian mitochondria. Proceedings of the National Academy of Sciences USA 105(48), 18735-18739.
81. Petros, J.A., Baumann, A.K., Ruiz-Pesini, E., et al. (2005). mtDNA mutations increase tumorigenicity in prostate cancer. Proceedings of the National Academy of Sciences USA 102(3), 719-724.
82. Potluri, P., Davila, A., Ruiz-Pesini, E., et al. (2009). A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease. Molecular Genetics and Metabolism 96(4), 189-195.
83. Procaccio, V. & Wallace, D.C. (2004). Late-onset Leigh syndrome in a patient with mitochondrial complex I NDUFS8 mutations. Neurology 62(10), 1899-1901.
84. Qi, X., Lewin, A.S., Hauswirth, W.W. & Guy, J. (2003a). Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Investigative Ophthalmology and Visual Science 44(3), 1088-1096.
85. Qi, X., Lewin, A.S., Hauswirth, W.W. & Guy, J. (2003b). Suppression of complex I gene expression induces optic neuropathy. Annals of Neurology 53(2), 198-205.
86. Qi, X., Lewin, A.S., Sun, L., Hauswirth, W.W. & Guy, J. (2004). SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Annals of Neurology 56(2), 182-191.
87. Raby, B.A., Klanderman, B., Murphy, A., et al. (2007). A common mitochondrial haplogroup is associated with elevated total serum IgE levels. Journal of Allergy and Clinical Immunology 120(2), 351-358.
88. Rasola, A. & Bernardi, P. (2007). The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12(5), 815-833.
89. Rose, G., Passarino, G., Carrieri, G., et al. (2001). Paradoxes in longevity: Sequence analysis of mtDNA haplogroup J in centenarians. European Journal of Human Genetics 9(9), 701-707.
90. Ruiz-Pesini, E. & Wallace, D.C. (2006). Evidence for adaptive selection acting on the tRNA and rRNA genes of the human mitochondrial DNA. Human Mutation 27(11), 1072-1081.
91. Ruiz-Pesini, E., Mishmar, D., Brandon, M., Procaccio, V. & Wallace, D.C. (2004). Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303(5655), 223-226.
92. Ruiz-Pesini, E., Lott, M.T., Procaccio, V., et al. (2007). An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Research 35(Database issue), D823-D828.
93. Rustin, P., von Kleist-Retzow, J.C., Chantrel-Groussard, K., Sidi, D., Munnich, A. & Rotig, A. (1999). Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study. Lancet 354(9177), 477-479.
94. Saada, A., Shaag, A., Mandel, H., Nevo, Y., Eriksson, S. & Elpeleg, O. (2001). Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nature Genetics 29(3), 342-344.
95. Santra, S., Gilkerson, R.W., Davidson, M. & Schon, E.A. (2004). Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Annals of Neurology 56(5), 662-669.
96. Saxena, R., de Bakker, P.I., Singer, K., et al. (2006). Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. American Journal of Human Genetics 79(1), 54-61.
97. Schaefer, A.M., Taylor, R.W., Turnbull, D.M. & Chinnery, P.F. (2004). The epidemiology of mitochondrial disorders-past, present and future. Biochimica et Biophysica Acta 1659(2-3), 115-120.
98. Schaefer, A.M., McFarland, R., Blakely, E.L., et al. (2007). Prevalence of mitochondrial DNA disease in adults. Annals of Neurology 63(1), 35-39.
99. Scott, R.A., Wilson, R.H., Goodwin, W.H., et al. (2005). Mitochondrial DNA lineages of elite Ethiopian athletes. Comparative Biochemistry and Physiology Part B, Biochemistry and Molecular Biology 140(3), 497-503.
100. Scott, R.A., Fuku, N., Onywera, V.O., et al. (2009). Mitochondrial haplogroups associated with elite Kenyan athlete status. Medicine and Science in Sports and Exercise 41(1), 123-128.
101. Seo, B.B., Kitajima-Ihara, T., Chan, E.K., Scheffler, I.E., Matsuno-Yagi, A. & Yagi, T. (1998). Molecular remedy of complex I defects: Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proceedings of the National Academy of Sciences USA 95(16), 9167-9171.
102. Seo, B.B., Wang, J., Flotte, T.R., Yagi, T. & Matsuno-Yagi, A. (2000). Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. Journal of Biological Chemistry 275(48), 37774-37778.
103. Seo, B.B., Nakamaru-Ogiso, E., Flotte, T.R., Yagi, T., and Matsuno-Yagi, A. (2002). A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. Molecular Therapy 6(3), 336-341.
104. Seo, B.B., Nakamaru-Ogiso, E., Cruz, P., Flotte, T.R., Yagi, T. & Matsuno-Yagi, A. (2004). Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: A potential therapy for complex I deficiencies. Human Gene Therapy 15(9), 887-895.
105. Shoffner, J.M., Lott, M.T., Voljavec, A.S., Soueidan, S.A., Costigan, D.A. & Wallace, D.C. (1989). Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy. Proceedings of the National Academy of Sciences USA 86(20), 7952-7956.
106. Shoffner, J.M., Lott, M.T., Lezza, A.M., Seibel, P., Ballinger, S.W. &Wallace, D.C. (1990). Myoclonic epilepsy and raggedred fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61(6), 931-937.
107. Shoffner, J.M., Brown, M.D., Torroni, A., et al. (1993). Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17(1), 171-184.
108. Shulman, A.I. & Mangelsdorf, D.J. (2005). Retinoid x receptor heterodimers in the metabolic syndrome. New England Journal of Medicine 353(6), 604-615.
109. Smeitink, J. & van den Heuvel, L. (1999). Human mitochondrial complex I in health and disease. American Journal of Human Genetics 64(6), 1505-1510.
110. Smith, R.A., Porteous, C.M., Gane, A.M. & Murphy, M.P. (2003). Delivery of bioactive molecules to mitochondria in vivo. Proceedings of the National Academy of Sciences USA 100(9), 5407-5412.
111. Sonoda, J., Mehl, I.R., Chong, L.W., Nofsinger, R.R. & Evans, R.M. (2007). PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proceedings of the National Academy of Sciences USA 104(12), 5223-5228.
112. Sonoda, J., Pei, L., Evans, R.M. (2008). Nuclear receptors: Decoding metabolic disease. FEBS Letters 582(1), 2-9.
113. Spelbrink, J.N., Li, F.Y., Tiranti, V., et al. (2001). Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nature Genetics 28(3), 223-231.
114. Srivastava, S., Barrett, J.N. & Moraes, C.T. (2007). PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Human Molecular Genetics 16(8), 993-1005.
115. Stacpoole, P.W., Kerr, D.S., Barnes, C., et al. (2006). Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 117(5), 1519-1531.
116. Stewart, J.B., Freyer, C., Elson, J.L., et al. (2008). Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biology 6(1), e10.
117. Suissa, S., Wang, Z., Poole, J., et al. (2009). Ancient mtDNA genetic variants modulate mtDNA transcription and replication. PLoS Genetics 5(5), e1000474.
118. Tachibana, M., Sparman, M., Sritanaudomchai, H., et al. (2009). Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461(7262), 367-372.
119. Tanaka, M., Gong, J.S., Zhang, J., Yoneda, M. & Yagi, K. (1998). Mitochondrial genotype associated with longevity. Lancet 351(9097), 185-186.
120. Tanaka, M., Gong, J., Zhang, J., Yamada, Y., Borgeld, H.J. & Yagi, K. (2000). Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mechanisms of Ageing and Development 116(2-3), 65-76.
121. Taylor, R.W., Chinnery, P.F., Clark, K.M., Lightowlers, R.N. & Turnbull, D.M. (1997a). Treatment of mitochondrial disease. Journal of Bioenergetics and Biomembranes 29(2), 195-205.
122. Taylor, R.W., Chinnery, P.F., Turnbull, D.M. & Lightowlers, R.N. (1997b). Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nature Genetics 15(2), 212-215.
123. Tiranti, V., Hoertnagel, K., Carrozzo, R., et al. (1998). Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. American Journal of Human Genetics 63(6), 1609-1621.
124. Tong, J., Schriner, S.E., McCleary, D., Day, B.J. & Wallace, D.C. (2007). Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster. Nature Genetics 39(4), 476-485.
125. Torroni, A., Petrozzi, M., D'Urbano, L., et al. (1997). Haplotype and phylogenetic analyses suggest that one Europeanspecific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. American Journal of Human Genetics 60(5), 1107-1121.
126. Trounce, I., Neill, S. &Wallace, D.C. (1994). Cytoplasmic transfer of the mtDNA nt 8993 TG (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proceedings of the National Academy of Sciences USA 91(18), 8334-8338.
127. Udar, N., Atilano, S.R., Memarzadeh, M., et al. (2009). Mitochondrial DNA haplogroups associated with age-related macular degeneration. Investigative Ophthalmology and Visual Science 50(6), 2966-2974.
128. van der Walt, J.M., Nicodemus, K.K., Martin, E.R., et al. (2003). Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. American Journal of Human Genetics 72(4), 804-811.
129. van der Walt, J.M., Dementieva, Y.A., Martin, E.R., et al. (2004). Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neuroscience Letters 365(1), 28-32.
130. Van Goethem, G., Dermaut, B., Lofgren, A., Martin, J.J. & Van Broeckhoven, C. (2001). Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nature Genetics 28(3), 211-212.
131. Van Goethem, G., Martin, J.J. & Van Broeckhoven, C. (2003). Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: Unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification. Neuromolecular Medicine 3(3), 129-146.
132. Wallace, D.C. (1982). Cytoplasmic inheritance of chloramphenicol resistance in mammalian cells. In: J.W. Shay (ed.) Techniques in Somatic Cell Genetics, pp. 159-187. Plenum Press, New York, NY.
133. Wallace, D.C. (1987). Maternal genes: Mitochondrial diseases. In: V.A. McKusick, T.H. Roderick, J. Mori & M.W. Paul (eds) Medical and Experimental Mammalian Genetics: A Perspective, pp. 137-190. A.R. Liss, Inc, New York, NY.
134. Wallace, D.C. (2005a). The mitochondrial genome in human adaptive radiation and disease: On the road to therapeutics and performance enhancement. Gene 354, 169-180.
135. Wallace, D.C. (2005b). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annual Review of Genetics 39, 359-407.
136. Wallace, D.C. (2007). Why do we have a maternally inherited mitochondrial DNA? Insights from Evolutionary Medicine. Annual Review of Biochemistry 76, 781-821.
137. Wallace, D.C. (2009). Mitochondria, bioenergetics, and the epigenome in eukaryotic and human evolution (in press). In: B. Stillman, D. Stewart & J. Wirtkowski (eds) Cold Spring Harbor Symposia on Quantitative Biology LXXIV Evolution: The Molecular Landscape, pp. 383-393. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
138. Wallace, D.C & Fan, W. (2009). The pathophysiology of mitochondrial disease as modeled in the mouse. Genes and Development 23(15), 1714-1736.
139. Wallace, D.C. & Fan, W. (2010). Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10(1), 12-31.
140. Wallace, D.C. & Lott, M.T. (2002). Mitochondrial genes in degenerative diseases, cancer and aging. In: D.L. Rimoin, J.M. Connor, R.E. Pyeritz & B.R. Korf (eds) Emery and Rimoin's Principles and Practice of Medical Genetics, pp. 299-409. Churchill Livingstone, London.
141. Wallace, D.C., Singh, G., Lott, M.T., et al. (1988). Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242(4884), 1427-1430.
142. Wallace, D.C., Brown, M.D. & Lott, M.T. (1999). Mitochondrial DNA variation in human evolution and disease. Gene 238(1), 211-230.
143. Wallace, D.C., Lott, M.T. & Procaccio, V. (2007). Mitochondrial genes in degenerative diseases, cancer and aging. In: D.L. Rimoin, J.M. Connor, R.E. Pyeritz & B.R. Korf (eds) Emery and Rimoin's Principles and Practice of Medical Genetics, 5th Edition, pp. 194-298. Churchill Livingstone Elsevier, Philadelphia, PA.
144. Wallace, D.C., Fan, W. & Procaccio, V. (2010). Mitochondrial energetics and therapeutics. Annual Review of Pathology 5, 297-348.
145. Wang, Y.X., Zhang, C.L., Yu, R.T., et al. (2004). Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biology 2(10), e294.
146. Wenz, T., Diaz, F., Spiegelman, B.M. & Moraes, C.T. (2008). Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metabolism 8(3), 249-256.
147. Zhu, Z., Yao, J., Johns, T., et al. (1998). SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genetics 20(4), 337-343.
148. Zuchner, S., Mersiyanova, I.V., Muglia, M., et al. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nature Genetics 36(5), 449-451.
149. Zuchner, S., Mersiyanova, I.V., Muglia, M., et al. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nature Genetics 36(5), 449-451.